4//SEC Filing
Fortress Biotech, Inc. 4
Accession 0001638599-16-001415
$FBIOCIK 0001429260operating
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:23 PM ET
Size
7.0 KB
Accession
0001638599-16-001415
Insider Transaction Report
Form 4
Avgerinos George
SVP, Biologics Operations
Transactions
- Sale
Common Stock, par value $0.001
2016-09-15$2.54/sh−15,000$38,100→ 293,000 total - Sale
Common Stock, par value $0.001
2016-09-16$2.55/sh−33,912$86,476→ 259,088 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades ranging from $2.49 to $2.58. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]This transaction was executed in multiple trades ranging from $2.53 to $2.62. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001429260
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:23 PM ET
- Size
- 7.0 KB